Increase in Young-Onset Colorectal Cancer
Introduction
A recent report shows an increase in the number of colorectal cancer cases being detected. This coincides with the new recommendation to start screening people with average risk at the age of 45, instead of the previous age of 50. The rise in cases is a significant finding and could potentially have a positive impact on early detection and treatment of this type of cancer.
Key Details
The American Cancer Society recommends that adults at average risk of colorectal cancer start regular screening at age 45. This change was made due to the rising number of cases in younger adults. Some possible factors contributing to this trend are unhealthy lifestyle choices, such as poor diet and lack of exercise, and increasing rates of obesity and diabetes. Additionally, studies have shown that certain genetic mutations may play a role in the development of colorectal cancer in younger individuals.
Impact
The increase in colorectal cancer cases being detected at an earlier age is a positive development. Early detection is crucial in the successful treatment of cancer. With more people being screened at the recommended age of 45, there is a higher chance of catching the disease in its early stages, when it is more treatable. This also highlights the importance of following recommended screening guidelines and making healthy lifestyle choices to reduce the risk of developing colorectal cancer. By being aware of the potential risk factors, we can take necessary precautions to protect
About the Organizations Mentioned
American Cancer Society
The **American Cancer Society (ACS)** is a leading nationwide voluntary health organization dedicated to eliminating cancer by preventing it, saving lives, and reducing suffering through research, education, advocacy, and service. Founded on May 22, 1913, by ten physicians and five businessmen in New York City as the "American Society for the Control of Cancer," it was established to break the stigma and ignorance surrounding cancer, a disease then shrouded in fear and silence[1][2][7]. At its inception, the ACS prioritized public education, launching nationwide campaigns including articles in popular magazines and professional journals, a monthly bulletin called *Campaign Notes*, and even a silent film to encourage early diagnosis[1][3]. Early funding came from philanthropists like John D. Rockefeller Jr., enabling the organization to grow slowly but steadily[2]. A major shift occurred in 1945 when Mary Lasker, a prominent philanthropist, influenced the ACS to focus heavily on cancer research. This led to a reorganization and a renaming to the American Cancer Society, accompanied by significant fundraising efforts—over $4 million raised in the first campaign—ushering in a new era of scientific discovery[4]. The ACS has since been instrumental in many key medical advances, including supporting the development of chemotherapy, promoting the Pap test which reduced cervical cancer deaths by 70%, confirming the link between smoking and lung cancer that led to major declines in smoking rates, and proving mammography’s efficacy in early breast cancer detection[5]. Today, ACS operates through 13 division offices, more than 3,000 community offices, and a volunteer network exceeding 2 million people nationwide[7]. Its innovation arm, BrightEdge, launched in 2019, exemplifies its commitment to leveraging venture capital and impact investments to accelerate cancer research and technology[5]. The ACS remains a vital force in cancer prevention, treatment innovation, and policy advocacy, continuously advancing the fight against cancer over its 110+ year histor